Iris Pharma

La Gaude, France Founded: 1989 • Age: 37 yrs Acquired By Abionyx
A contract research organization offering preclinical and clinical research services to ophthalmology companies

About Iris Pharma

Iris Pharma is a Healthcare company based in La Gaude (France) founded in 1989, and was acquired by Abionyx in November 2021. A contract research organization offering preclinical and clinical research services to ophthalmology companies. Iris Pharma offers products and services including Preclinical Services, Clinical Trial Services, and Early Testing Services. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service.

Company details

Iris Pharma was founded in 1989 in La Gaude, France, as a contract research organization focused on the ophthalmology sector. Services offered include in vivo ocular efficacy studies, preclinical research, bioanalysis, clinical trials, and marketing surveys. Operations support ophthalmology companies in drug and device development, with contributions made to the market entry of approximately 70 ocular products.

  • Headquarters La Gaude, France
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website iris-pharma.com
  • Social LinkedIn
  • Acquired by Abionyx (Nov 2021)
Key Metrics

Products & Services of Iris Pharma

Iris Pharma offers a comprehensive portfolio of products and services, including Preclinical Services, Clinical Trial Services, and Early Testing Services.

Preclinical Services
Research Services

Conducts in vivo pharmacology and safety studies for ocular compounds

Clinical Trial Services
Trial Management

Manages phases of clinical trials for ophthalmic indications

Early Testing Services
Preliminary Research

Performs efficacy and pharmacokinetics testing for ocular therapies

Investors in Iris Pharma

Iris Pharma has secured backing from 1 investor. Prominent investors backing the company include Abionyx.

All
InvestorDescriptionFounded YearDomainLocation
Therapeutics for rare diseases and severe inflammatory conditions are developed.
2005abionyx.comBalma, France
Premium access

Investor details for Iris Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Iris Pharma

2 dated milestones of Iris Pharma across 32 years, from founding to its latest funding, stage changes and deals.

  1. Founded Iris Pharma is founded.
  2. Exit Acquired by Abionyx.

Web traffic of Iris Pharma

The website of Iris Pharma (iris-pharma.com) receives about 2.2K visits a month and ranks #10,426,473 among all websites worldwide, #7,909 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    2.2K

    ▲ 64% vs previous month

  • Global rank
    #10,426,473

    among all websites

  • Category rank
    #7,909

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Iris Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
eyecro.com
100%
1.9K#10,504,025View details
incresearch.com
98%
View details
celerion.com
95%
25.4K#1,182,554View details
resverlogix.com
95%
4.7K#3,235,284View details
pharmaasia.com
pharmaasia.com
95%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 9 similar websites and full traffic analytics for Iris Pharma

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 9 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Iris Pharma

Premium access

Complete news archive for Iris Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Iris Pharma

Iris Pharma was founded in 1989.

Iris Pharma is headquartered in La Gaude, France. It is registered at La Gaude, Alpes-maritimes, France.

Iris Pharma was founded in 1989 in La Gaude, France, as a contract research organization focused on the ophthalmology sector. Services offered include in vivo ocular efficacy studies, preclinical research, bioanalysis, clinical trials, and marketing surveys. Operations support ophthalmology companies in drug and device development, with contributions made to the market entry of approximately 70 ocular products.

Iris Pharma offers Preclinical Services, Clinical Trial Services, and Early Testing Services.

Iris Pharma has 1 investor. Key investors include Abionyx.

Yes. Iris Pharma was acquired by Abionyx in November 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available